James Comey faces new classified information allegations, but prosecutors confront major statute-of-limitations challenge
HoloMD names former Eliza founder Irene Lang CEO, but can continuous AI monitoring become a scalable psychiatry business?
Read More Pharma Industry News Repligen targets up to $852m in 2026 sales as cell therapy acquisition reshapes portfolio Repligen raises its 2026 sales forecast to $844M–$852M after record quarterly revenue, strong organic growth and its BioLife acquisition. bySoujanya RaviOctober 27, 2026